FRANKFURT, Oct 12 (Reuters) - Germany's Fresenius Medical Care (FMEG.DE) said that use of Ozempic and other diabetes and weight-loss drugs of the same class would have an overall neutral effect on how many patients would require the company's kidney dialysis services in the future.
FRANKFURT, June 27 (Reuters) - Shares in kidney dialysis group Fresenius Medical Care (FMEG.DE) fell as much as 5% on Tuesday after a payment increase proposed by a major U.S. public health insurance body fell short of market expectations.
Enforcement Report - Week of June 7, 2023
FRANKFURT, May 9 (Reuters) - Fresenius Medical Care (FMEG.DE) said on Tuesday labour shortages were slowly easing as the German dialysis specialist reported a drop in first-quarter adjusted operating income that was not as steep as some analysts had expected.
BAD HOMBURG, Germany, Feb 22 (Reuters) - Fresenius Medical Care (FMEG.DE) shares hit their highest level in nearly seven months on Wednesday, welcoming news that FMC parent Fresenius would cede control over the struggling dialysis firm but keep its stake for now as part of a turnaround plan.
Enforcement Report - Week of December 14, 2022
After months of lead-up, Carla Kriwet, Ph.D., lasted only a few weeks at the helm of Fresenius Medical Care.
Enforcement Report - Week of October 26, 2022
Fresenius cut to Hold at Jefferies citing staffing issues and inflation
US District Judge Maryellen Noreika of Delaware ruled on Thursday that Teva’s generic candidate for Velphoro — which has yet to be approved — would infringe on a patent held by Vifor Fresenius Medical Care Renal Pharma (VFMCRP), which is now part of CSL Vifor.